October 21, 2024
The Power of Key Business Questions
In our biopharma world, we frequently hear the term “Key Business Questions (KBQs).” And while it’s often thrown around…
Strategy and Planning,All Categories,Decision-Making and Process
September 24, 2024
The Underappreciated Value of New Product Planning
The value of New Product Planning (NPP) is often overlooked, but it plays a crucial role in the success of drug…
Strategy and Planning,All Categories,Decision-Making and Process
August 21, 2024
Biopharma Annual Planning Success: Close Your Rings Year-Round
How do we think about biopharma annual planning differently? The analogy we will draw on is fitness trackers and…
Strategy and Planning,All Categories,Decision-Making and Process
July 22, 2024
The Power of Target Product Profiles: Three Case Studies
In the biopharma industry, the Target Product Profile (TPP) is a critical tool for guiding the development and…
Strategy and Planning,All Categories,Decision-Making and Process
June 25, 2024
Unlocking Success: The Power of Target Product Profiles
In the ever-evolving biopharma landscape, success hinges not just on innovation but also on a clear roadmap guiding…
Strategy and Planning,All Categories,Decision-Making and Process
May 22, 2024
Unfinished Business on the Glass Ceiling
Reflecting on my career and the significant societal and technological shifts during those years, I see it as split…
Organizational Development and Culture,All Categories,Relationship Building
April 23, 2024
Governance: The Glue to a Successful Launch
At the core of every successful launch lies a meticulously crafted plan, a robust governance structure, and expert…
Strategy and Planning,All Categories,Decision-Making and Process
March 26, 2024
Your Biopharma Data Needs a Strategy
In the not-so-distant past, physician prescribing data was essentially a commodity with limited breadth or depth for…
Strategy and Planning,All Categories,Decision-Making and Process
February 8, 2024
Success in Rare Disease: Patient Involvement Matters!
This past December, the FDA finalized its guidance on rare diseases with the publication Rare Diseases: Considerations…
January 24, 2024
Juggling Geographic Commercialization Priorities
Commercializing a pharmaceutical asset in one country is hard enough. Doing it on a global scale, with multiple country…
Strategy and Planning,All Categories,Decision-Making and Process









